Literature DB >> 2802224

Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: a case report.

M A Ashburn1, P G Fine, T H Stanley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2802224     DOI： 10.1097/00000542-198910000-00026

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

1.  Anesthesia for the 21st century.

Authors:  T H Stanley
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-01

Review 2.  Oral transmucosal fentanyl. Help or hindrance?

Authors:  M A Ashburn; J B Streisand
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

3.  [Use of rapid-onset fentanyl preparations beyond indication : A random questionnaire survey among congress participants and pain physicians].

Authors:  Stefan Wirz; Michael Schenk; Hannes Hofbauer; Hans-Christian Wartenberg; Marco Cascella; Kristin Kieselbach
Journal:  Schmerz       Date:  2020-09-25       Impact factor: 1.107

4.  [New modes of opioid administration.].

Authors:  H W Striebel; R Schwagmeier; N Boerger
Journal:  Schmerz       Date:  1993-09       Impact factor: 1.107

5.  [Intranasal fentanyl for breakthrough cancer pain. A pilot study.].

Authors:  H W Striebel; A Wessel; A Rieger
Journal:  Schmerz       Date:  1993-09       Impact factor: 1.107
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.